Stanley Stewart Davis

Stanley Stuart (Bob) Davis (born 17 December 1942) is emeritus professor of pharmacy at the University of Nottingham.

For other people named Stanley Davis, see Stanley Davis (disambiguation).

Stanley Stewart Davis
Born1942
Warwick, England
NationalityBritish
Alma materUniversity of London
AwardsScheele Award
Scientific career
FieldsChemistry
InstitutionsUniversity of Nottingham

Early life and education

Davis was born in Warwick, England. He obtained his bachelor's degree in pharmacy from the School of Pharmacy at the University of London in 1964. He remained at the same university to study for a PhD in colloid science (1967).

Academic career

In 1966 he was appointed assistant lecturer in pharmaceutics and then to lecturer in 1967. He was awarded his Doctor of Science degree (higher doctorate) in 1982. In 1968 he was awarded a one-year Fulbright Scholarship to undertake postdoctoral studies with Takeru Higuchi at the University of Kansas, US, in the field of solution thermodynamics.

In 1970 he moved to the University of Aston in Birmingham as senior lecturer and head of the pharmaceutics section. Here, he built up an active research group in drug delivery systems. Davis took the position of Lord Trent Professor of Pharmacy at the University of Nottingham in 1975, where he ran a large research group, studying novel drug delivery systems.[1] Topics of research have included drug targeting (with particular emphasis on colloidal carriers), transmucosal delivery, oral and parenteral systems for controlled release and product evaluation through gamma scintigraphy.[2] He became an emeritus professor in 2003.

He has published over 750 papers and is co-editor of 7 books. He is the named inventor on numerous patents dealing with drug delivery. He is the founder and chairman of Cosmas-Damian a consulting company that provides services to the pharmaceutical and biotechnology industries. This company has been in existence for more than 25 years and is based on his extensive experience. He is also the co-founder of three pharmaceutical companies; CDD (Co-ordinated Drug Development) (since acquired by Vectura Group); Danbiosyst (UK) Ltd (sold to West Pharmaceutical Services and then to Archimedes) and Pharmaceutical Profiles Ltd.

Other work

He has acted as a consultant to various pharmaceutical companies and has worked as a visiting scientist at Syntex, Allergan, and Alza.[1] He has served on numerous committees and panels, to include those of the British and European Pharmacopoeias, the United Kingdom Medicines Commission, The Science & Engineering Research Council.

Awards and recognition

Davis has received The Science Medal (The British Pharmaceutical Conference, 1971), The Scheele Award (Swedish Pharmaceutical Association, 1985), The Maurice-Marie Janot Award (APGI, France, 1986) (The Harrison Memorial Medal, Royal Pharmaceutical Society of Great Britain, 2000), The Eurand Career Achievement Award for Outstanding Research in Oral Drug Delivery. The Controlled Release Society, 2003. The Hoest Madsen Medal (FIP) (2005).[1]

References
  1. "Curriculum Vitae Professor Stanley (Bob) Davis". CosmasDamian Ltd.
  2. Akhtar, Saghir (December 2010). "In honor of Professor S. S. (Bob) Davis, Recipient of the Journal of Drug Targeting 's Life-time Achievement Award for 2010". Journal of Drug Targeting. 18 (10): 701. doi:10.3109/1061186X.2010.529268. PMID 21047270. S2CID 39202657.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.